News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
R3 Seminar Recap: Using RECOVER biosamples to advance your research
On January 13, 2026, RECOVER hosted the second webinar in its 2-part series to help prospective researchers use biosamples from the initiative’s observational studies. RECOVER has made over 1.4 million biosamples available for study across the human lifespan, including 24,000 samples from its tissue pathology (autopsy) study. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
148 Results
148 Results
Researchers invited to submit proposals for new round of ancillary pathobiology studies
RECOVER released a call for ancillary pathobiology study proposals that will build on the more than 60 existing funded studies and will address unanswered questions about Long COVID.
Feature
Electronic health record study examines how COVID-19 severity impacts risk of autoimmune diseases
Researchers found that severe COVID-19 can cause a strong immune response, which can cause the body’s immune system to attack itself and lead to new autoimmune diseases.
Feature
Researcher Spotlight: Shari B. Brosnahan, MD
Drawing on her experience working in intensive care, expertise in lung health, and knowledge of medical imaging, Dr. Brosnahan is leading studies that could inform the development of treatments for specific Long COVID symptoms.
Feature
RECOVER study finds that social and economic hardship increase risk for Long COVID
A study published in Annals of Internal Medicine—led by RECOVER researchers at Mass General Brigham—shows financial hardship, food insecurity, lack of healthcare access, and other social risk factors increase the risk for Long COVID.
Announcement
R3 Seminar Recap: Characterizing Long COVID during early childhood
At a recent RECOVER Research Review (R3) Seminar held July 8, RECOVER researchers Rachel Gross, MD, MS; and Tanayott (Tony) Thaweethai, PhD, presented key findings from their study recently published in Journal of the American Medical Association (JAMA) Pediatrics. They were joined by RECOVER Representatives Krista Coombs and Megan Carmilani, who shared personal stories and reflections about the study findings. Amy Salisbury, PhD, RN, FAAN, a coauthor of the publication, facilitated the discussion.
R3 Seminar Recap
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature
NIH consultation service helps RECOVER research to reach communities in need
A team of community engagement experts from NIH’s Community Engagement Alliance Consultative Resource (CEACR) is helping RECOVER meet the needs of communities most impacted by Long COVID.
Feature
R3 Seminar Recap: Long COVID after SARS-CoV-2 during pregnancy
During a recent RECOVER Research Review (R3) seminar, RECOVER researchers Torri Metz, MD, MS, Chengxi Zang, PhD, and Valerie Flaherman, MD, MPH, shared findings from two major studies examining the risk of developing Long COVID following a SARS-CoV-2 infection during pregnancy. Drawing on data from RECOVER’s observational study of pregnant women and from two national electronic health record (EHR) research networks, these studies represent some of the largest efforts to date exploring the relationship between pregnancy and Long COVID.
R3 Seminar Recap